These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2343456)
1. Preventive effect of zinc against cadmium-induced bone resorption. Suzuki Y; Morita I; Yamane Y; Murota S Toxicology; 1990 May; 62(1):27-34. PubMed ID: 2343456 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of the effects of cadmium on the release of calcium and on the activity of some enzymes from neonatal mouse calvaria in culture. Carlsson L; Lundholm CE Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):251-6. PubMed ID: 9375363 [TBL] [Abstract][Full Text] [Related]
3. Stimulative effects of cadmium on bone resorption in neonatal parietal bone resorption. Miyahara T; Takata M; Mori-Uchi S; Miyata M; Nagai M; Sugure A; Matsusista M; Kozuka H; Kuze S Toxicology; 1992; 73(1):93-9. PubMed ID: 1589882 [TBL] [Abstract][Full Text] [Related]
4. Cadmium stimulates prostaglandin E2 production and bone resorption in cultured fetal mouse calvaria. Suzuki Y; Morita I; Yamane Y; Murota S Biochem Biophys Res Commun; 1989 Jan; 158(2):508-13. PubMed ID: 2916999 [TBL] [Abstract][Full Text] [Related]
5. Cadmium-induced calcium release and prostaglandin E2 production in neonatal mouse calvaria are dependent on cox-2 induction and protein kinase C activation. Romare A; Lundholm CE Arch Toxicol; 1999; 73(4-5):223-8. PubMed ID: 10463387 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. Lerner UH J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism. Linkhart TA; MacCharles DC Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698 [TBL] [Abstract][Full Text] [Related]
9. Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro. Krieger NS; Frick KK; LaPlante Strutz K; Michalenka A; Bushinsky DA J Bone Miner Res; 2007 Jun; 22(6):907-17. PubMed ID: 17352658 [TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria. O'Brien EA; Williams JH; Marshall MJ Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid. Koide M; Okahashi N; Tanaka R; Kazuno K; Shibasaki K; Yamazaki Y; Kaneko K; Ueda N; Ohguchi M; Ishihara Y; Noguchi T; Nishihara T Arch Oral Biol; 1999 Sep; 44(9):711-9. PubMed ID: 10471155 [TBL] [Abstract][Full Text] [Related]
13. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H; Härkönen PL; Väänänen HK; Hentunen TA J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [TBL] [Abstract][Full Text] [Related]
14. IL-1beta regulates cellular proliferation, prostaglandin E2 synthesis, plasminogen activator activity, osteocalcin production, and bone resorptive activity of the mouse calvarial bone cells. Kim CH; Kang BS; Lee TK; Park WH; Kim JK; Park YG; Kim HM; Lee YC Immunopharmacol Immunotoxicol; 2002 Aug; 24(3):395-407. PubMed ID: 12375736 [TBL] [Abstract][Full Text] [Related]
15. Phorbol myristate acetate stimulates osteoclast formation in 1 alpha,25-dihydroxyvitamin D3-primed mouse embryonic calvarial cells by a prostaglandin-dependent mechanism. Amano S; Hanazawa S; Kawata Y; Nakada Y; Miyata Y; Kitano S J Bone Miner Res; 1994 Apr; 9(4):465-72. PubMed ID: 8030434 [TBL] [Abstract][Full Text] [Related]
16. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption. Stern PH; Alvares K J Cell Biochem; 2014 Nov; 115(11):2033-8. PubMed ID: 25042887 [TBL] [Abstract][Full Text] [Related]
17. Role of tumor necrosis factor alpha in particulate-induced bone resorption. Algan SM; Purdon M; Horowitz SM J Orthop Res; 1996 Jan; 14(1):30-5. PubMed ID: 8618163 [TBL] [Abstract][Full Text] [Related]
18. Systematic assessment of bone resorption, collagen synthesis, and calcification in chick embryonic calvaria in vitro: effects of prostaglandin E2. Nagai M; Suzuki Y; Ota M Bone; 1993; 14(4):655-9. PubMed ID: 8274309 [TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. van't Hof RJ; Ralston SH J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684 [TBL] [Abstract][Full Text] [Related]
20. Homologous and heterologous control of bone cell adenosine 3',5'-monophosphate response to hormones by parathoromone, prostaglandin E2, calcitonin, and 1,25-dihydroxycholecalciferol. Kent GN; Jilka RL; Cohn DV Endocrinology; 1980 Nov; 107(5):1474-81. PubMed ID: 6253267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]